DK2244783T3 - Flygtige anæstetiske sammensætninger og fremgangsmåder til anvendelse - Google Patents

Flygtige anæstetiske sammensætninger og fremgangsmåder til anvendelse Download PDF

Info

Publication number
DK2244783T3
DK2244783T3 DK09704014.1T DK09704014T DK2244783T3 DK 2244783 T3 DK2244783 T3 DK 2244783T3 DK 09704014 T DK09704014 T DK 09704014T DK 2244783 T3 DK2244783 T3 DK 2244783T3
Authority
DK
Denmark
Prior art keywords
methods
volatile anesthetic
anesthetic compositions
compositions
volatile
Prior art date
Application number
DK09704014.1T
Other languages
Danish (da)
English (en)
Inventor
Allen Burton
Phillip C Phan
Christopher C Capelli
Hatice Ozsoy
Original Assignee
Univ Texas
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Texas filed Critical Univ Texas
Application granted granted Critical
Publication of DK2244783T3 publication Critical patent/DK2244783T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/075—Ethers or acetals
    • A61K31/08—Ethers or acetals acyclic, e.g. paraformaldehyde
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/075—Ethers or acetals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0085—Brain, e.g. brain implants; Spinal cord
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dispersion Chemistry (AREA)
  • Psychology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Immunology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Anesthesiology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK09704014.1T 2008-01-22 2009-01-22 Flygtige anæstetiske sammensætninger og fremgangsmåder til anvendelse DK2244783T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US1189808P 2008-01-22 2008-01-22
PCT/US2009/031707 WO2009094460A2 (en) 2008-01-22 2009-01-22 Volatile anesthetic compositions and methods of use

Publications (1)

Publication Number Publication Date
DK2244783T3 true DK2244783T3 (da) 2020-03-16

Family

ID=40901623

Family Applications (1)

Application Number Title Priority Date Filing Date
DK09704014.1T DK2244783T3 (da) 2008-01-22 2009-01-22 Flygtige anæstetiske sammensætninger og fremgangsmåder til anvendelse

Country Status (10)

Country Link
US (3) US20110159078A1 (enExample)
EP (1) EP2244783B1 (enExample)
JP (2) JP5835542B2 (enExample)
CN (1) CN102006903A (enExample)
AU (1) AU2009206391A1 (enExample)
CA (1) CA2712516C (enExample)
DK (1) DK2244783T3 (enExample)
ES (1) ES2765007T3 (enExample)
PL (1) PL2244783T3 (enExample)
WO (1) WO2009094460A2 (enExample)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008036858A2 (en) 2006-09-20 2008-03-27 The Board Of Regents Of The University Of Texas System Methods for delivering volatile anesthetics for regional anesthesia and/or pain relief
WO2009094459A1 (en) * 2008-01-22 2009-07-30 The Board Of Regents Of The University Of Texas System Volatile anesthetic compositions comprising extractive solvents for regional anesthesia and/or pain relief
CN102006903A (zh) * 2008-01-22 2011-04-06 维波真尼克斯公司 挥发性麻醉组合物和应用方法
WO2010025505A1 (en) * 2008-09-04 2010-03-11 Phebra Pty Ltd Analgesia by transmucosal administration
CA3031836A1 (en) * 2009-05-05 2010-11-11 Board Of Regents, The University Of Texas System Formulations of volatile anesthetics for reducing inflammation
EP2345427A1 (de) * 2010-01-14 2011-07-20 SapioTec GmbH Flurankomplex
DE102010042615A1 (de) 2010-10-19 2012-04-19 Wacker Chemie Ag 1:1, 2:1- oder 3:1-Komplex bestehend aus einem Cyclodextrin oder Cyclodextrinderivat und einem halogeniertem Ether, seine Herstellung und seine Verwendung als Schlafmittel
CA2839670C (en) * 2011-06-20 2016-05-24 Dmf Medical Incorporated An anesthetic circuit and a method for using the anesthetic circuit
CN107260670A (zh) * 2011-06-24 2017-10-20 维普詹尼克斯公司 用于治疗皮肤病症或疾病的新型制剂和方法
GB201116271D0 (en) * 2011-09-21 2011-11-02 Univ Cardiff Dispersion anaesthetic device
US11083696B2 (en) * 2011-09-21 2021-08-10 University College Cardiff Consultants Limited Dispersion anaesthetic device
US10076620B2 (en) 2012-12-22 2018-09-18 Dmf Medical Incorporated Anesthetic circuit having a hollow fiber membrane
JP6669645B2 (ja) * 2013-03-15 2020-03-18 ベイポジェニックス インコーポレイテッド 新規な鎮痛組成物
CN108348703A (zh) 2015-07-20 2018-07-31 医疗发展国际有限公司 用于可吸入液体的吸入器装置
RU2717638C2 (ru) 2015-07-20 2020-03-24 Медикал Дивелопментс Интернэшнл Лимитед Ингаляторное устройство для ингаляционных жидкостей
AU2016295425B2 (en) 2015-07-20 2020-09-24 Medical Developments International Limited Inhaler device for inhalable liquids
CN109803702B (zh) 2016-09-06 2022-04-12 医疗发展国际有限公司 用于可吸入液体的吸入器装置
US12480926B2 (en) 2018-03-19 2025-11-25 Trustees Of Boston University Systems, devices, and methods for ultrasonic agitation mediated kinetic release testing of compounds
JP7692438B2 (ja) 2020-06-02 2025-06-13 メディカル、ディベロップメンツ、インターナショナル、リミテッド 吸入可能な液体用の吸入装置

Family Cites Families (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4879062A (en) * 1981-10-20 1989-11-07 Adamantech, Inc. Preparation of a gel having gas transporting capability
US4725442A (en) * 1983-06-17 1988-02-16 Haynes Duncan H Microdroplets of water-insoluble drugs and injectable formulations containing same
US4622219A (en) 1983-06-17 1986-11-11 Haynes Duncan H Method of inducing local anesthesia using microdroplets of a general anesthetic
US4744989A (en) * 1984-02-08 1988-05-17 E. R. Squibb & Sons, Inc. Method of preparing liposomes and products produced thereby
US5091188A (en) * 1990-04-26 1992-02-25 Haynes Duncan H Phospholipid-coated microcrystals: injectable formulations of water-insoluble drugs
US5114715A (en) 1990-11-29 1992-05-19 Sepracor Inc. Methods of use and compositions of (s)-isoflurane and (s)-desflurane
US5114714A (en) 1990-11-29 1992-05-19 Sepracor, Inc. Methods of use and compositions of (r)-isoflurane and (r)-desflurane
US5416071A (en) * 1991-03-12 1995-05-16 Takeda Chemical Industries, Ltd. Water-soluble composition for sustained-release containing epo and hyaluronic acid
BE1005163A3 (fr) 1991-08-01 1993-05-11 Solvay Compositions contenant un ether fluore et utilisation de ces compositions.
US5283372A (en) 1991-12-04 1994-02-01 Anaquest, Inc. Preparation of purified optical isomers of desflurane
US5230778A (en) * 1992-05-01 1993-07-27 Gavlin Associates Purification of isoflurane by extractive distillation
AU704918B2 (en) * 1995-06-07 1999-05-06 Alliance Pharmaceutical Corporation Reverse fluorocarbon emulsion compositions for drug delivery
US5747058A (en) * 1995-06-07 1998-05-05 Southern Biosystems, Inc. High viscosity liquid controlled delivery system
US5874469A (en) * 1996-01-05 1999-02-23 Alcon Laboratories, Inc. Fluoroalkyl hydrocarbons for administering water insoluble or unstable drugs
US5861175A (en) * 1996-03-15 1999-01-19 Alliance Pharmaceutical Corp. Use of fluorocarbons for diagnosis and treatment of articular disorders
DE19709704C2 (de) 1997-03-10 1999-11-04 Michael Georgieff Verwendung einer flüssigen Präparation von Xenon zur intravenösen Verabreichung bei Einleitung und/oder Aufrechterhaltung der Anaesthesie
US20050287075A1 (en) * 1997-10-01 2005-12-29 Dugger Harry A Iii Buccal, polar and non-polar spray or capsule containing drugs for treating pain
US20030185761A1 (en) 1997-10-01 2003-10-02 Dugger Harry A. Buccal, polar and non-polar spray or capsule containing drugs for treating pain
GB2350297A (en) 1999-05-27 2000-11-29 Abbott Lab Injectable halogenated anesthetic formulation in emulsion form
US6673363B2 (en) * 1999-12-16 2004-01-06 Dermatrends, Inc. Transdermal and topical administration of local anesthetic agents using basic enhancers
EP1363602A4 (en) * 2001-01-25 2006-01-11 Euro Celtique Sa LOCAL ANESTHESIA, AND METHOD OF USE
US20030027833A1 (en) * 2001-05-07 2003-02-06 Cleary Gary W. Compositions and delivery systems for administration of a local anesthetic agent
CN1703209A (zh) 2002-10-11 2005-11-30 巴克斯特国际公司 通过静脉施用卤化挥发性麻醉药保护心脏和保护神经的方法
WO2005009510A2 (en) * 2003-07-23 2005-02-03 The Regents Of The University Of California Penetration enhancer combinations for transdermal delivery
AU2004280118B2 (en) * 2003-10-10 2009-01-15 Imperial Innovations Limited Use of xenon with hypothermia for treating neonatal asphyxia
US8557861B2 (en) * 2004-09-28 2013-10-15 Mast Therapeutics, Inc. Low oil emulsion compositions for delivering taxoids and other insoluble drugs
US20060198891A1 (en) * 2004-11-29 2006-09-07 Francois Ravenelle Solid formulations of liquid biologically active agents
WO2008036858A2 (en) * 2006-09-20 2008-03-27 The Board Of Regents Of The University Of Texas System Methods for delivering volatile anesthetics for regional anesthesia and/or pain relief
US9000048B2 (en) * 2006-11-28 2015-04-07 Wisconsin Alumni Research Foundation Fluoropolymer-based emulsions for the intravenous delivery of fluorinated volatile anesthetics
CN102006903A (zh) * 2008-01-22 2011-04-06 维波真尼克斯公司 挥发性麻醉组合物和应用方法
WO2009094459A1 (en) * 2008-01-22 2009-07-30 The Board Of Regents Of The University Of Texas System Volatile anesthetic compositions comprising extractive solvents for regional anesthesia and/or pain relief
CA3031836A1 (en) 2009-05-05 2010-11-11 Board Of Regents, The University Of Texas System Formulations of volatile anesthetics for reducing inflammation

Also Published As

Publication number Publication date
US9566251B2 (en) 2017-02-14
JP2014240420A (ja) 2014-12-25
US20170112783A1 (en) 2017-04-27
WO2009094460A2 (en) 2009-07-30
US20130273141A1 (en) 2013-10-17
CA2712516A1 (en) 2009-07-30
WO2009094460A3 (en) 2009-12-30
JP5952357B2 (ja) 2016-07-13
EP2244783A2 (en) 2010-11-03
CA2712516C (en) 2016-06-28
ES2765007T3 (es) 2020-06-05
EP2244783A4 (en) 2011-03-09
US20110159078A1 (en) 2011-06-30
PL2244783T3 (pl) 2020-08-24
JP5835542B2 (ja) 2015-12-24
JP2011510092A (ja) 2011-03-31
CN102006903A (zh) 2011-04-06
AU2009206391A1 (en) 2009-07-30
EP2244783B1 (en) 2019-12-18

Similar Documents

Publication Publication Date Title
DK2244783T3 (da) Flygtige anæstetiske sammensætninger og fremgangsmåder til anvendelse
DK3795573T3 (da) Bestemte triazolopyraziner, sammensætninger deraf og fremgangsmåder til anvendelse deraf
DK3345625T3 (da) Farmaceutisk sammensætning og indgivelser deraf
DK2334378T3 (da) Prodrugs af methylhydrogenfumarat, farmaceutiske sammensætninger deraf og fremgangsmåder til anvendelse
DK3252057T3 (da) Multicykliske forbindelser og fremgangsmåder til anvendelse deraf
DK2272339T3 (da) Fremgangsmåder og præparater til anvendelse med geldispensere
DK2419670T3 (da) Leveringsmetode og sammensætninger
DK2185164T3 (da) Sammensætning og terapeutisk antitumorvaccine
DK2796469T3 (da) Hidtil ukendte sammensætninger og fremgangsmåder til behandling af IgE-medierede forstyrrelser
DK3278665T3 (da) Stabil farmaceutisk sammensætning og fremgangsmåder til anvendelse deraf
BRPI1011587A2 (pt) compostos e composições terapèuticas
DK2220116T3 (da) Sammensætninger og fremgangsmåder til terapien og diagnosticeringen af influenza
DK2504353T4 (da) Lipopeptidsammensætninger og tilsvarende fremgangsmåder
DK2475372T4 (da) Fremgangsmåde til fremstilling af micro-RNA og dets terapeutiske anvendelse
DK3202460T3 (da) Arylmethoxy-isoindolinderivater og sammensætninger omfattende og fremgangsmåder til anvendelser af samme
DK2069467T3 (da) Adskillende sammensætninger og fremgangsmåder til anvendelse
PL3812360T3 (pl) Związki monochlorotrifluoropropenu oraz kompozycje i sposoby ich zastosowania
LT2695609T (lt) Per burną vartojamos citidino analogų kompozicijos ir jų panaudojimo būdai
DK2322221T3 (da) Farmaceutisk sammensætning til behandling og forebyggelse af cancer
DK2379096T3 (da) TFPI-inhibitorer og fremgangsmåder til anvendelse
DK2254634T3 (da) Inhalator og sigte til en inhalator
FI20096058A0 (fi) Koostumuksia ja niihin liittyviä menetelmiä ja käyttöjä
EP2298365A4 (en) MEDICAL COMPOSITION AND MEDICAL KIT
BRPI0918206A2 (pt) derivados de animoéster e composição medicinal destes
BRPI0913398A2 (pt) composição e métodos de adesivo para dentaduras